Effects of progesterone on normal and preneoplastic mammary development in mice in relation to prolactin and estrogen.
D000818:Animals; D004967:Estrogens / Q000378:metabolism; D004971:Estrus / Q000187:drug effects; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000633:toxicity; D016729:Leuprolide; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000254:growth & development; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000473:pathology; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D011247:Pregnancy; D011374:Progesterone / Q000097:blood / Q000633:toxicity*; D011388:Prolactin / Q000097:blood*; D011453:Prostaglandins / Q000633:toxicity; D014599:Uterus / Q000473:pathology
D004967:Estrogens; D011453:Prostaglandins; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D011388:Prolactin; D016729:Leuprolide